These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 29437961

  • 1. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles.
    Tu T, Budzinska MA, Vondran FWR, Shackel NA, Urban S.
    J Virol; 2018 Jun 01; 92(11):. PubMed ID: 29437961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.
    Gastroenterology; 2014 Apr 01; 146(4):1070-83. PubMed ID: 24361467
    [Abstract] [Full Text] [Related]

  • 5. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):808-13. PubMed ID: 24342612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C, Chakraborty A, Chou WM, Hasreiter J, Wettengel JM, Stadler D, Bester R, Asen T, Zhang K, Wisskirchen K, McKeating JA, Ryu WS, Protzer U.
    J Hepatol; 2018 Dec 17; 69(6):1231-1241. PubMed ID: 30142426
    [Abstract] [Full Text] [Related]

  • 8. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
    Kaneko S, Kakinuma S, Asahina Y, Kamiya A, Miyoshi M, Tsunoda T, Nitta S, Asano Y, Nagata H, Otani S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Nakauchi H, Nishitsuji H, Ujino S, Shimotohno K, Iwamoto M, Watashi K, Wakita T, Watanabe M.
    Sci Rep; 2016 Jul 08; 6():29358. PubMed ID: 27386799
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
    Yan Y, Allweiss L, Yang D, Kang J, Wang J, Qian X, Zhang T, Liu H, Wang L, Liu S, Sui J, Chen X, Dandri M, Zhao J, Lu F.
    Emerg Microbes Infect; 2019 Jul 08; 8(1):879-894. PubMed ID: 31179847
    [Abstract] [Full Text] [Related]

  • 10. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T, Hikita H, Murai K, Nozaki Y, Kai Y, Makino Y, Saito Y, Tanaka S, Wada H, Eguchi H, Takahashi T, Suemizu H, Sakamori R, Hiramatsu N, Tatsumi T, Takehara T.
    Sci Rep; 2016 Jun 09; 6():27782. PubMed ID: 27278060
    [Abstract] [Full Text] [Related]

  • 11. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
    Fukano K, Oshima M, Tsukuda S, Aizaki H, Ohki M, Park SY, Wakita T, Wakae K, Watashi K, Muramatsu M.
    J Virol; 2021 Nov 23; 95(24):e0093821. PubMed ID: 34613794
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S.
    J Hepatol; 2014 Apr 23; 60(4):723-31. PubMed ID: 24295872
    [Abstract] [Full Text] [Related]

  • 15. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.
    Lee J, Zong L, Krotow A, Qin Y, Jia L, Zhang J, Tong S, Li J.
    J Virol; 2018 Aug 01; 92(15):. PubMed ID: 29793953
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
    Zhao K, Liu S, Chen Y, Yao Y, Zhou M, Yuan Y, Wang Y, Pei R, Chen J, Hu X, Zhou Y, Zhao H, Lu M, Wu C, Chen X.
    Emerg Microbes Infect; 2018 Nov 21; 7(1):186. PubMed ID: 30459339
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NTCP opens the door for hepatitis B virus infection.
    Yan H, Liu Y, Sui J, Li W.
    Antiviral Res; 2015 Sep 21; 121():24-30. PubMed ID: 26071008
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A, Döring B, Mohr C, Geipel A, Geyer J, Glebe D.
    J Hepatol; 2014 Oct 21; 61(4):867-75. PubMed ID: 24845614
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.